Cargando…
Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer
Cisplatin is used to treat multiple types of solid tumor, including gastric cancer. Although cisplatin initially exhibits good efficacy, therapeutic failure often occurs owing to the development of chemoresistance. To the best of our knowledge, the underlying mechanism of cisplatin resistance remain...
Autores principales: | Duan, Shuquan, Yin, Jie, Bai, Zhigang, Zhang, Zhongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950176/ https://www.ncbi.nlm.nih.gov/pubmed/29805561 http://dx.doi.org/10.3892/ol.2018.8390 |
Ejemplares similares
-
Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin
por: LIU, LIANCHENG, et al.
Publicado: (2016) -
Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
por: FENG, LIN, et al.
Publicado: (2015) -
Mcl-1 stabilization confers resistance to taxol in human gastric cancer
por: Shuang, Wu, et al.
Publicado: (2017) -
Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
por: Zaffaroni, N., et al.
Publicado: (1998) -
Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer
por: Xu, Bodong, et al.
Publicado: (2019)